MCC Global Laboratories, Inc. Moves from France to Massachusetts
Beverly, MA – June 1, 2015– MCC Global Laboratories Inc., developers of Elephant™, an innovative terminal cleaning solution for the healthcare market, announced the opening of their new offices in Beverly, MA. MCC now has office space in the North Shore InnoVentures incubator at the Cummings Center in Beverly after relocating operations from France.
“Massachusetts’ thriving life sciences community has become a magnet for companies that want to be where the action is,” said Governor Charlie Baker. “We welcome MCC Global, and look forward to partnering with them to create jobs, and further economic growth and development.”
MCC manufactures and distributes a simple, low-cost, and highly effective infection control solution that eliminates biological threats in critical spaces in healthcare environments, called Elephant™. The technology was developed in France and tested in French hospitals and blood banks. Protecting healthcare workers and patients from infection is a challenge in France, as well as the US where 1 in 25 patients gets an infection during a stay at a healthcare facility.
“We felt that the United States would be the best location for our headquarters, since it is the largest healthcare market in the world,” says Loutfi Kachou, MCC Founder and Elephant’s inventor. “We were also attracted by Massachusetts’ international reputation for medical technology. Our new product adapts very well to the terminal cleaning practices in the US.”
Finding the necessary resources is difficult for any startup, but finding them in a new country is a major challenge. “We were aided by a number of Massachusetts agencies. MOITI (Massachusetts Office of International Trade and Investment) plugged us into the right networks. And, I cannot say enough for the Massachusetts Life Science Center, which was instrumental in having us choose Massachusetts over any other region,” said Gina Kachou, COO and Co-Founder. “We will be moving our product development and manufacturing to Massachusetts as well.”
“It is welcome news that MCC Global Laboratories chose Beverly for its US offices. This region of the state has become a hotbed of activity in the life sciences sector, and this decision shows that state investment in biotech and other high tech sectors is resulting in job creation and economic development,” said State Representative Jerry Parisella (D-Beverly).
“We needed to form a management team and hire staff that understood the market, the technology and could help us make the move,” said Dan Bandar, MCC’s board member. “North Shore InnoVentures paired us up with advisors, legal and other services, and before long we were a new American company.” Martha Farmer, CEO of North Shore InnoVentures (www.NSIV.org), said, “MCC is addressing a serious problem in our healthcare system with their innovative technology and we are delighted to be able to facilitate that.”
“We are delighted to welcome MCC to Massachusetts, the world’s leading ecosystem for life sciences innovation and growth,” said Angus McQuilken, Vice President for Communications & Marketing for the MLSC. “We’ve been in dialogue with MCC for the past year about their location plans, and we are confident that their new Beverly location will allow them to find the talent, customers and partners they need here to maximize their success and future growth.”
“MCC is going to get a great reception in the US and other markets,” says David Bertoni, MCC CEO. “Hospitals and other healthcare facilities are striving for better healthcare delivery and lower costs. MCC’s Elephant delivers on both, offering complete decontamination of critical spaces at lower costs than conventional terminal cleaning.”
MCC recently competed successfully for one of the first round of grants through the MLSC’s Milestone Achievement Program (MAP). Last week the MLSC announced a $200,000 grant award for MCC to help the company achieve a clinical/regulatory milestone.
About MCC Global Laboratories, Inc.
MCC Labs manufactures and distributes an effective, low-cost, surface, biological decontamination products for healthcare, industry and bio-defense, world-wide. MCC Labs has developed a simple, low-cost, and highly effective infection control solution to eliminate biological threats in healthcare spaces, called Elephant™. Elephant reduces the risk of infection by providing >6-log reduction of viruses, bacteria, bacterial spores and fungi on exposed surfaces. In addition to being superior to conventional terminal cleaning, Elephant reduces costs and requires no capital outlay. For more information, visit www.mccgloballabs.com.
About the Massachusetts Life Sciences Center
The Massachusetts Life Sciences Center (MLSC) is an investment agency that supports life sciences innovation, research, development and commercialization. The MLSC is charged with implementing a 10-year, $1-billion, state-funded investment initiative. These investments create jobs and support advances that improve health and well-being. The MLSC offers the nation’s most comprehensive set of incentives and collaborative programs targeted to the life sciences ecosystem. These programs propel the growth that has made Massachusetts the global leader in life sciences. The MLSC creates new models for collaboration and partners with organizations, both public and private, around the world to promote innovation in the life sciences. For more information, visit masslifesciences.com.
Martha Farmer, Ph.D.
President & CEO
North Shore InnoVentures
KCSA Strategic Communications